Therapeutic plasma exchange may allow patients with advanced melanoma to overcome immune checkpoint inhibitor resistance, data suggest.

The Inflation Reduction Act has decreased Medicare Part D expenditures and the total cost of care under the Enhancing Oncology Model but has not reduced total drug spending, data suggest.

First-line treatment with disitamab vedotin and toripalimab improved outcomes over chemotherapy in patients with HER2-expressing, locally advanced or metastatic urothelial carcinoma.

Long preoperative chemo elicited more pathologic complete responses than short preoperative chemo in PDAC, but no difference in EFS was seen.

The incidence rates for invasive lobular carcinoma increased from 2012 to 2021 for all racial and ethnic groups, according to a study published in Cancer.